Jabarpour M, Pouri S, Aleyasin A, Shabani Nashtaei M, Najafian A
Arch Gynecol Obstet. 2024; 309(5):1999-2008.
PMID: 38421423
DOI: 10.1007/s00404-024-07387-4.
Szukiewicz D
Int J Mol Sci. 2024; 25(4).
PMID: 38396659
PMC: 10889014.
DOI: 10.3390/ijms25041976.
Johnson C, Duncan M, Murphy M
J Alzheimers Dis. 2023; 97(1):31-74.
PMID: 38007653
PMC: 10842753.
DOI: 10.3233/JAD-230527.
Yacca S, Kanasaki H, Tumurbaatar T, Cairang Z, Oride A, Okada H
Endocrine. 2023; 83(3):733-746.
PMID: 37966704
DOI: 10.1007/s12020-023-03596-0.
Yang L, Liang F, Yuan Y, Luo X, Wang Q, Yao L
Front Endocrinol (Lausanne). 2023; 14:1224858.
PMID: 37795363
PMC: 10546405.
DOI: 10.3389/fendo.2023.1224858.
Validation of a new Custom Polyclonal Progesterone Receptor Antibody for Immunohistochemistry in the Female Mouse Brain.
Ruddenklau A, Glendining K, Prescott M, Campbell R
J Endocr Soc. 2023; 7(10):bvad113.
PMID: 37693686
PMC: 10492226.
DOI: 10.1210/jendso/bvad113.
Progestin-primed ovarian stimulation for fertility preservation in women with cancer: A comparative study.
Filippi F, Reschini M, Polledri E, Cecchele A, Guarneri C, Vigano P
PLoS One. 2023; 18(3):e0280238.
PMID: 36976781
PMC: 10047511.
DOI: 10.1371/journal.pone.0280238.
Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management.
Sarafoglou K, Merke D, Reisch N, Claahsen-van der Grinten H, Falhammar H, Auchus R
J Clin Endocrinol Metab. 2023; 108(9):2154-2175.
PMID: 36950738
PMC: 10438890.
DOI: 10.1210/clinem/dgad134.
Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome.
Hernandez-Jerez A, Adriaanse P, Aldrich A, Berny P, Coja T, Duquesne S
EFSA J. 2023; 21(2):e07744.
PMID: 36818642
PMC: 9926893.
DOI: 10.2903/j.efsa.2023.7744.
A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions.
Emanuel R, Roberts J, Docherty P, Lunt H, Campbell R, Moller K
Front Endocrinol (Lausanne). 2022; 13:1017468.
PMID: 36457554
PMC: 9705998.
DOI: 10.3389/fendo.2022.1017468.
Targeting KNDy neurons to control GnRH pulses.
Constantin S
Curr Opin Pharmacol. 2022; 67:102316.
PMID: 36347163
PMC: 9772270.
DOI: 10.1016/j.coph.2022.102316.
Adaptive, reversible, hypothalamic reproductive suppression: More than functional hypothalamic amenorrhea.
Prior J
Front Endocrinol (Lausanne). 2022; 13:893889.
PMID: 36339445
PMC: 9626525.
DOI: 10.3389/fendo.2022.893889.
The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.
Alemany M
Int J Mol Sci. 2022; 23(19).
PMID: 36233256
PMC: 9569951.
DOI: 10.3390/ijms231911952.
Acute progesterone feedback on gonadotropin secretion is not demonstrably altered in estradiol-pretreated women with polycystic ovary syndrome.
Kim S, Lundgren J, Patrie J, Burt Solorzano C, McCartney C
Physiol Rep. 2022; 10(7):e15233.
PMID: 35384387
PMC: 8981178.
DOI: 10.14814/phy2.15233.
Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent Fertilization/Intracytoplasmic Sperm Injection Cycles: Comparing With....
Chen C, Yu S, Yu W, Yan Z, Jin W, Si J
Front Physiol. 2022; 12:744968.
PMID: 35222055
PMC: 8874211.
DOI: 10.3389/fphys.2021.744968.
The role of gonadotropin-releasing hormone neurons in polycystic ovary syndrome.
McCartney C, Campbell R, Marshall J, Moenter S
J Neuroendocrinol. 2022; 34(5):e13093.
PMID: 35083794
PMC: 9232905.
DOI: 10.1111/jne.13093.
Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS)-A 6-Month Pilot Study of a Single Woman's Experience Changes.
Shirin S, Murray F, Goshtasebi A, Kalidasan D, Prior J
Medicina (Kaunas). 2021; 57(10).
PMID: 34684061
PMC: 8538639.
DOI: 10.3390/medicina57101024.
Progestin-Primed Ovarian Stimulation Protocol for Patients in Assisted Reproductive Technology: A Meta-Analysis of Randomized Controlled Trials.
Guan S, Feng Y, Huang Y, Huang J
Front Endocrinol (Lausanne). 2021; 12:702558.
PMID: 34531825
PMC: 8438422.
DOI: 10.3389/fendo.2021.702558.
Comparison of the effects of Duphaston and Cetrotide on oocyte and embryo quality in women undergoing ICSI: A cross-sectional study.
Motaref N, Jouhari S, Mohammadzadeh A, Kazemnejad S, Madadi N, Eghtedari S
Int J Reprod Biomed. 2020; 18(11):975-982.
PMID: 33349806
PMC: 7749970.
DOI: 10.18502/ijrm.v13i11.7965.
Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial.
Wang N, Zhu Q, Ma M, Liang Z, Tao Y, Wang Y
BMJ Open. 2020; 10(12):e038153.
PMID: 33268401
PMC: 7713223.
DOI: 10.1136/bmjopen-2020-038153.